SGLT2 inhibitors: A driving force to improved standard-of-care in CKD

31 Mar 2023 13:00 14:00

MR 109 CDHG

Organized by Science Collected. Supported by an unrestricted educational grant from AstraZeneca

Carol Pollock Chairperson University of SydneyAustralia

Organized by

Supported by an unrestricted educational grant from AstraZeneca

Time	Session

13:00 13:05	Welcome and Introductions Carol Pollock Speaker University of SydneyAustralia
13:05 13:25	Three-pronged protection – mortality, cardiovascular, and kidney benefits with SGLT2 inhibitors Sydney Tang Speaker The University of Hong KongHong Kong, China
13:25 13:35	Old problems, new solutions – practical approaches to optimising care Carol Pollock Speaker University of SydneyAustralia
13:35 13:45	Is it too late? An opportunity to intervene early Mustafa Arici Speaker
13:45 13:55	Panel discussion and Q and A
13:55 14:00	Closing remarks Carol Pollock Speaker University of SydneyAustralia